Cingulate Inc.
Leadership moves, last update 3 weeks ago
Pharma biotech · Headquarters United States
Everything we hold on Cingulate Inc., newest first. Every line links to the filing or report it came from.
- 2026-07-23Headcount Not Stated Leadership moves
Cingulate Inc. Announces Departure of Chief Legal Officer
The Chief Legal Officer role at Cingulate Inc. in Kansas City is being eliminated, affecting legal and compliance functions.
- 2026-07-02Headcount Not Stated Leadership moves
Cingulate Inc. Announces Leadership Change
Matthew N. Brams' trial period for full-time employment as Executive Vice President and Chief Medical Officer at Cingulate Inc. has been extended.
- 2026-05-19Headcount Not Stated Leadership moves
Cingulate Inc. 8-K filing (Item 5.02): officer or director change
Cingulate Inc. in Kansas City will not re-elect two directors at its 2026 Annual Meeting, reducing its board size to five and appointing a new chairman.
- 2026-04-02Headcount Not Stated Leadership moves
Cingulate Inc. 8-K filing: officer or director change
Cingulate Inc. appoints a new board member in Kansas City, signaling leadership change in the pharma and biotech sector.
- 2026-02-17Headcount Not Stated Leadership moves
Cingulate Inc. 8-K filing (Item 5.02): officer or director change
Cingulate Inc. has undergone a leadership change in Kansas City; the filing does not disclose any immediate impact on hiring or roles.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker